Anticoagulant Treatment in Progressing Stroke*
Anticoagulant Treatment in Progressing Stroke*
复制标题
进展性中风的抗凝治疗*
DOI：
10.1136/bmj.2.5244.70
复制
发表时间：
1961
影响因子：
--
通讯作者：
A. B. Carter
中科院分区：
文献类型：
--
作者：
A. B. Carter
两组患者的比较-一组主要接受胰岛素昏迷和E.C.T.治疗，另一组用氯丙嗪改良胰岛素和心电图- 后一组显示出显著的优势，并且axerage停留时间从10.7周减少到6.3周。比较随访也证实了后一组治疗结果的优越性。所使用的方法和优势，治疗选定的精神分裂症患者在综合医院设置进行了讨论。
A comparison of two groups of patients-one treated predominantly with insulin coma and E.C.T., and the other with chlorpromazine, modified insulin, and E.C.T. -shows a significant advantage for the latter group, and a reduction of the axerage stay from 10.7 to 6.3 weeks. A comparative follow-up also confirms the superiority of the results of treatment in the latter group. The methods used and the advantages of treating selected schizophrenic patients in a general-hospital setting are also discussed.